IOL CHEMICALS & PHARM. | HIKAL. | IOL CHEMICALS & PHARM./ HIKAL. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | 53.8 | 25.6% | View Chart |
P/BV | x | 1.6 | 3.4 | 46.2% | View Chart |
Dividend Yield | % | 1.0 | 0.4 | 258.4% |
IOL CHEMICALS & PHARM. HIKAL. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
HIKAL. Mar-23 |
IOL CHEMICALS & PHARM./ HIKAL. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 456 | 117.6% | |
Low | Rs | 272 | 216 | 126.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 164.1 | 230.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | 6.4 | 372.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 15.2 | 207.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 1.20 | 333.3% | |
Avg Dividend yield | % | 1.0 | 0.4 | 276.9% | |
Book value per share (Unadj.) | Rs | 256.8 | 91.9 | 279.4% | |
Shares outstanding (eoy) | m | 58.71 | 123.30 | 47.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.0 | 52.3% | |
Avg P/E ratio | x | 17.1 | 52.8 | 32.3% | |
P/CF ratio (eoy) | x | 12.8 | 22.1 | 58.0% | |
Price / Book Value ratio | x | 1.6 | 3.7 | 43.1% | |
Dividend payout | % | 16.9 | 18.9 | 89.4% | |
Avg Mkt Cap | Rs m | 23,743 | 41,420 | 57.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 2,224 | 75.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 20,230 | 109.6% | |
Other income | Rs m | 256 | 54 | 473.4% | |
Total revenues | Rs m | 22,427 | 20,284 | 110.6% | |
Gross profit | Rs m | 2,257 | 2,571 | 87.8% | |
Depreciation | Rs m | 462 | 1,090 | 42.3% | |
Interest | Rs m | 165 | 481 | 34.2% | |
Profit before tax | Rs m | 1,887 | 1,054 | 179.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 270 | 183.5% | |
Profit after tax | Rs m | 1,391 | 784 | 177.5% | |
Gross profit margin | % | 10.2 | 12.7 | 80.1% | |
Effective tax rate | % | 26.2 | 25.6 | 102.5% | |
Net profit margin | % | 6.3 | 3.9 | 162.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 9,683 | 99.8% | |
Current liabilities | Rs m | 5,025 | 6,908 | 72.7% | |
Net working cap to sales | % | 20.9 | 13.7 | 152.6% | |
Current ratio | x | 1.9 | 1.4 | 137.2% | |
Inventory Days | Days | 43 | 26 | 169.0% | |
Debtors Days | Days | 8 | 80 | 10.4% | |
Net fixed assets | Rs m | 11,017 | 15,024 | 73.3% | |
Share capital | Rs m | 587 | 247 | 238.1% | |
"Free" reserves | Rs m | 14,490 | 11,088 | 130.7% | |
Net worth | Rs m | 15,077 | 11,335 | 133.0% | |
Long term debt | Rs m | 0 | 4,899 | 0.0% | |
Total assets | Rs m | 20,684 | 24,707 | 83.7% | |
Interest coverage | x | 12.5 | 3.2 | 390.4% | |
Debt to equity ratio | x | 0 | 0.4 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.8 | 130.9% | |
Return on assets | % | 7.5 | 5.1 | 147.0% | |
Return on equity | % | 9.2 | 6.9 | 133.5% | |
Return on capital | % | 13.6 | 9.5 | 143.9% | |
Exports to sales | % | 26.7 | 67.6 | 39.5% | |
Imports to sales | % | 0 | 25.6 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 13,684 | 43.3% | |
Imports (cif) | Rs m | NA | 5,184 | 0.0% | |
Fx inflow | Rs m | 5,930 | 13,684 | 43.3% | |
Fx outflow | Rs m | 6,052 | 5,184 | 116.7% | |
Net fx | Rs m | -122 | 8,500 | -1.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 3,153 | 38.8% | |
From Investments | Rs m | -1,200 | -2,923 | 41.0% | |
From Financial Activity | Rs m | -41 | -77 | 53.5% | |
Net Cashflow | Rs m | -18 | 153 | -12.0% |
Indian Promoters | % | 48.2 | 68.9 | 70.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 10.1 | 16.9% | |
FIIs | % | 1.4 | 6.6 | 21.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 31.2 | 166.3% | |
Shareholders | 130,003 | 71,840 | 181.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | HIKAL CHEMIC | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.79% | -0.79% | 0.89% |
1-Month | 6.64% | 15.84% | 0.97% |
1-Year | 1.54% | 6.21% | 53.54% |
3-Year CAGR | -12.64% | 12.68% | 14.62% |
5-Year CAGR | 16.41% | 12.22% | 19.23% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the HIKAL CHEMIC share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of HIKAL CHEMIC the stake stands at 68.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of HIKAL CHEMIC.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
HIKAL CHEMIC paid Rs 1.2, and its dividend payout ratio stood at 18.9%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of HIKAL CHEMIC.
For a sector overview, read our pharmaceuticals sector report.
Japan's Nikkei 225 led gains in Asia as markets in the region rose across the board, following Wall Street's continued rally for a second straight day.